Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $5.4 Million - $22.4 Million
19,297,462 Added 17054.46%
19,410,614 $6.41 Million
Q1 2024

May 15, 2024

SELL
$1.06 - $1.67 $123,053 - $193,866
-116,088 Reduced 50.64%
113,152 $131,000
Q4 2023

Feb 14, 2024

SELL
$1.26 - $1.79 $804,784 - $1.14 Million
-638,718 Reduced 73.59%
229,240 $387,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $1.4 Million - $2.2 Million
867,958 New
867,958 $1.57 Million
Q1 2023

May 15, 2023

SELL
$1.2 - $2.19 $2.24 Million - $4.09 Million
-1,867,874 Reduced 89.29%
224,000 $297,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $3.41 Million - $7.36 Million
2,091,874 New
2,091,874 $3.54 Million
Q2 2022

Aug 15, 2022

SELL
$2.2 - $4.2 $127,756 - $243,898
-58,071 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.83 - $8.69 $164,340 - $504,636
58,071 New
58,071 $234,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.